The overwhelming demands on health care resources in treating patients with COVID-19 and the heterogeneity in illness presentation highlights the need for strategies to predict which individuals are at risk for greater symptom severity.
Asthma exacerbations dropped during the pandemic; what can be learned from this occurrence that may help lower exacerbation rates in the future?
Given the close relationship between IBS and mental health, the use of psychological modalities represents a growing area of interest in IBS management.
Pneumonia prevention interventions such as proper oral care, head-of-bed elevation, and incentive spirometry, are not being provided to most patients outside the ICU, leading to greater than two-thirds of hospital-acquired pneumonia.
There is debate regarding the specific interventions that constitute aerosol-generating procedures.
The benefits of telemedicine became more evident in the context of the elevated risk of COVID-19 infection and severe symptoms among the patients served by hematology and oncology practices.
The gains in the global fight against tuberculosis have been threatened as a result of the COVID-19 pandemic, including a diversion of resources that have led to disruptions in ongoing research and control programs.
In this interview, Richard Becker, MD, gives us an insight into COVID-19 vasculitis and its manifestations.
Findings suggest lower rates of COVID-19 infection and mortality in countries with universal neonatal BCG tuberculosis vaccination policies compared with countries without this practice.
Recent studies have led to important insights regarding the role of viruses in asthma pathogenesis and exacerbations, as well as mediating factors involved in these processes.
